How to optimize clinical trials in the commercial context

How to optimize clinical trials in the commercial context

March 15, 2017

Elpis Barons, CEO Trajan Accelerator Group, shared her experience about optimizing clinical trials, at the Devices and Diagnostics Lab on 15 March 2017 at The Auditorium @ 452 Flinders, Melbourne, Victoria, Australia.

Ms Barons joined ten other speakers, five expert panelists and four dynamic chair people to address innovation in medical devices with a focus on implantable medical technologies.

Complementing her role at Trajan, Ms Barons also provides clinical research consulting services to international medical technology organizations, device manufacturers and suppliers, as Director of Barons Medical Consulting.

Ms Barons explored the commercial context of clinical trials, and how to leverage international networks to provide input into clinical trial designs that will generate value beyond regulatory approval, and provide supporting data to cause the adoption of medical devices.

The event was hosted by BioMelbourne Network and supported by the Victorian State Government, CSIRO, Piper Alderman, and the Australian Government Department of Industry, Innovation and Science. It was a great opportunity for discussion between business leaders, entrepreneurs, investors, clinicians, researchers, product developers and industry experts across medical technology, ICT, engineering, design, manufacturing and health innovation.

You can download the presentation at the Barons Medical Consulting website.

More information
BioMelbourne Network Devices + Diagnostics Lab
Barons Medical Consulting

Media contact information
Tel: +44 (0) 1244 403 100
media@trajanscimed.com




Also in News

Trajan’s LEAP Technologies and Sierra Analytics team up to provide joint HDX solution
Trajan’s LEAP Technologies and Sierra Analytics team up to provide joint HDX solution

January 10, 2018

Trajan Scientific and Medical and Sierra Analytics today announced a partnership for Sierra’s HDExaminer software for Hydrogen-Deuterium Exchange (HDX) data analysis.

Read More

New joint venture, Trajan Nutrition
New joint venture, Trajan Nutrition

November 26, 2017

This week at the 10th Asia Pacific Conference on Clinical Nutrition (APCCN) we are delighted to showcase our newest business, Trajan Nutrition.

Read More

Congratulations to Trajan CSO on University of Tasmania award
Congratulations to Trajan CSO on University of Tasmania award

November 14, 2017

Dr Andrew Gooley, Chief Scientific Officer of Trajan Scientific and Medical, proudly accepted the University of Tasmania Vice-Chancellor's award for outstanding contributions by adjunct and clinical title holders.

Read More